These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11745467)

  • 1. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes.
    Zehbe I; Tachezy R; Mytilineos J; Voglino G; Mikyskova I; Delius H; Marongiu A; Gissmann L; Wilander E; Tommasino M
    Int J Cancer; 2001 Dec; 94(5):711-6. PubMed ID: 11745467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.
    Zehbe I; Mytilineos J; Wikström I; Henriksen R; Edler L; Tommasino M
    Hum Immunol; 2003 May; 64(5):538-42. PubMed ID: 12691704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer.
    Matsumoto K; Yasugi T; Nakagawa S; Okubo M; Hirata R; Maeda H; Yoshikawa H; Taketani Y
    Int J Cancer; 2003 Oct; 106(6):919-22. PubMed ID: 12918070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype.
    Zehbe I; Wilander E; Delius H; Tommasino M
    Cancer Res; 1998 Feb; 58(4):829-33. PubMed ID: 9485042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions.
    Andersson S; Alemi M; Rylander E; Strand A; Larsson B; Sällström J; Wilander E
    Br J Cancer; 2000 Aug; 83(3):307-10. PubMed ID: 10917543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV16 E6 variants and HLA class II polymorphism among Chinese women with cervical cancer.
    Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Xu A
    J Med Virol; 2007 Apr; 79(4):439-46. PubMed ID: 17311339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and evolutionary analysis of HPV16 E6 and E7 genes in Greek women.
    Tsakogiannis D; Papadopoulou A; Kontostathi G; Ruether IGA; Kyriakopoulou Z; Dimitriou TG; Orfanoudakis G; Markoulatos P
    J Med Microbiol; 2013 Nov; 62(Pt 11):1688-1696. PubMed ID: 23946477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers.
    Choi BS; Kim SS; Yun H; Jang DH; Lee JS
    J Med Virol; 2007 Apr; 79(4):426-30. PubMed ID: 17311337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease.
    Kämmer C; Tommasino M; Syrjänen S; Delius H; Hebling U; Warthorst U; Pfister H; Zehbe I
    Br J Cancer; 2002 Jan; 86(2):269-73. PubMed ID: 11870518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants.
    Gokhale PS; Sonawani A; Idicula-Thomas S; Kerkar S; Tongaonkar H; Mania-Pramanik J
    J Med Virol; 2014 Jun; 86(6):968-74. PubMed ID: 24610458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variations of E6 and long control region of human papillomavirus type 16 from patients with cervical lesion in Liaoning, China.
    Sun Z; Lu Z; Liu J; Wang G; Zhou W; Yang L; Liu C; Wang B; Ruan Q
    BMC Cancer; 2013 Oct; 13():459. PubMed ID: 24099556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
    de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
    Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus (HPV) 16 E6 variants in tonsillar cancer in comparison to those in cervical cancer in Stockholm, Sweden.
    Du J; Nordfors C; Näsman A; Sobkowiak M; Romanitan M; Dalianis T; Ramqvist T
    PLoS One; 2012; 7(4):e36239. PubMed ID: 22558401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression.
    Lee K; Magalhaes I; Clavel C; Briolat J; Birembaut P; Tommasino M; Zehbe I
    Virus Res; 2008 Jan; 131(1):106-10. PubMed ID: 17869365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6.
    Evans M; Borysiewicz LK; Evans AS; Rowe M; Jones M; Gileadi U; Cerundolo V; Man S
    J Immunol; 2001 Nov; 167(9):5420-8. PubMed ID: 11673561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus type 16 E6 and E7 gene variations in Indian cervical cancer.
    Radhakrishna Pillai M; Sreevidya S; Pollock BH; Jayaprakash PG; Herman B
    Gynecol Oncol; 2002 Dec; 87(3):268-73. PubMed ID: 12468324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV16 E6 gene variations in invasive cervical squamous cell carcinoma and cancer in situ from Russian patients.
    Hu X; Pang T; Guo Z; Mazurenko N; Kisseljov F; Pontén J; Nistér M
    Br J Cancer; 2001 Mar; 84(6):791-5. PubMed ID: 11259093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E6 gene polymorphism of Human papillomavirus 16 in relation to the risk of cervical cancer in Tunisian women.
    Bel Haj Rhouma R; Ardhaoui M; Othman H; Ben Jemia Z; Zine El Abidine A; Fehri E; Ouerheni K; Laassili T; Tounsi H; Guizani I; Boubaker MS; Ennaifer E
    Infect Genet Evol; 2023 Dec; 116():105536. PubMed ID: 38048896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III.
    Nimako M; Fiander AN; Wilkinson GW; Borysiewicz LK; Man S
    Cancer Res; 1997 Nov; 57(21):4855-61. PubMed ID: 9354449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancer.
    Hara M; Matsueda S; Tamura M; Takedatsu H; Tanaka M; Kawano K; Mochizuki K; Kamura T; Itoh K; Harada M
    Int J Oncol; 2005 Nov; 27(5):1371-9. PubMed ID: 16211234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.